← brief for 2026-09-01 · Slowing decline

Long-term cardiorenal illness trajectories after initiation of antihypertensive medications in adults with and without ADHD: a nationwide cohort study

Paper C Peer reviewed Observational

Key takeaways

Researchers used national health records to follow adults who started blood pressure medicine, comparing those with ADHD to those without, and tracked heart and kidney illness over years. This is a large observational cohort, so it can show a link but cannot prove that ADHD or its treatment changes kidney outcomes. Blood pressure control is one of the main levers for slowing kidney decline, so differences in who stays on treatment matter. The record has no abstract, so the number of people and the size of any difference are not available.

Who did this work

Yiling Zhou (University Medical Center Groningen) · Douwe Postmus (University Medical Center Groningen) · Sheyu Li (Sichuan University) · Anne van Lammeren (Medisch Centrum Leeuwarden) · Casper Franssen (University Medical Center Groningen) · Harold Snieder (University Medical Center Groningen) · Catharina A. Hartman (University Medical Center Groningen)

Source

Paper · OpenAlex, CKD works · 2026-08-31
https://doi.org/10.1038/s44220-026-00718-1